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Purpose: Transforming growth factor-β2 (TGF-β2), basic fibroblast growth factor (bFGF), and fibromodulin (FMOD)
are important extracellular matrix components of the sclera and have been shown to be associated with the development
of high myopia. Our aim was to examine the association between myopia and the polymorphisms within TGF-β2,
bFGF, and FMOD.
Methods: The study group comprised of patients (n=195; age range: 17−24 years) with a spherical equivalent of −6.5
diopters (D) or a more negative refractive error. The control group comprised of individuals (n=94; age range: 17−25
years) with a spherical equivalent ranging from −0.5 D to +1.0 D. The subjects with astigmatism over –0.75 D were
excluded from the study. High resolution melting (HRM) genotyping and restriction fragment length polymorphism
(RFLP) genotyping were used to detect single nucleotide polymorphisms (SNPs). The polymorphisms detected were TGF-
β2 (rs7550232 and rs991967), bFGF (rs308395 and rs41348645), and FMOD (rs7543418). Moreover, a stepwise logistic
regression procedure was used to detect which of the significant SNPs contributed to the main effects of myopia
development.
Results: There were significant differences in the frequency of the A allele and A/A genotype in TGF-β2 (rs7550232;
p=0.0178 and 0.03, respectively). Moreover, the haplotype distribution of haplotype 2 (Ht2; A/A) of TGF-β2 differed
significantly between the two groups (p=0.014). The results of the stepwise logistic regression procedure revealed that
TGF-β2 (rs7550232) contributed significantly to the development of high myopia.
Conclusions: TGF-β2 is an important structure of sclera and might contribute to the formation of myopia. TGF-β2
(rs7550232) polymorphisms, A allele and A/A genotype, had a protective role against the development of high myopia.
The prevalence of myopia ranges from 20% to 30% in
North American, European, and Australian populations [1]
and is as high as 90% in Asian populations [2,3]. Low to
moderate  degrees  of  myopia  present  a  relatively  minor
inconvenience as the symptoms are easily corrected using
spectacles or contact lenses. High degrees of myopia, while
also correctable using these optical approaches, are of major
concern  because  of  the  increased  risk  of  myopia-related
pathology  such  as  chorioretinal  degeneration  and  retinal
detachment [4]. The ocular pathology associated with high
myopia is among the leading causes of registered blindness in
the developed world [5].
Many studies have suggested that myopia is a complex
disease  with  multiple  causes,  including  the  interaction  of
multiple genes with environmental stimuli [6]. Therefore, it
is necessary to take both genes and environment into account
to understand myopia [6]. As for pathogenesis of high myopia,
studies of high myopia in animal models have demonstrated
that increasing eye size facilitated by remodeling of the sclera
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was one of the most important etiologies in the progression of
myopia [7]. The sclera consists of fibrous connective tissue
comprised largely of heterologous collagen fibrils, which are
in  turn  composed  mainly  of  type  I  collagen  with  small
amounts of other fibrillar and fibril-associated collagens [8].
An important candidate in the search for factors involved in
scleral remodeling in myopia is transforming growth factor-β
(TGF-β). Transforming growth factor-β is known to initiate
myofibroblast  formation  and  fibrosis  [9].  Although  five
members of the TGF-β family have currently been identified,
only TGF-β isoforms 1, 2, and 3 have been detected in eyes
and TGF-β2 is the predominant form [9,10].
In  addition  to  TGF-β,  basic  fibroblast  growth  factors
(bFGFs) are also involved in the remodeling of sclera. bFGFs
with  their  receptors  (FGFRs)  and  signaling  cascades  are
involved in a diverse range of cellular processes including
proliferation,  apoptosis,  cell  survival,  chemotaxis,  cell
adhesion, motility, and differentiation. bFGF-2 is a potent
mitogen for fibroblasts and myofibroblasts [11]. Moreover,
the  major  extracellular  matrix  components  of  the  fibrous
mammalian sclera are collagen types I and III and the small
leucine rich proteoglycans (SLRPs), which include decorin,
biglycan, lumican, and fibromodulin (FMOD) [12]. There is
considerable evidence that FMOD is involved in regulating
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1655the formation of the network of collagen fibrils that makes up
the  extracellular  matrix  [13].  Among  the  polymorphisms,
rs7550232 (TGF-β2) and rs308395 (bFGF) are found in the
promoter  region  and  rs991967  (TGF-β2)  and  rs41348645
(bFGF) are found in the 3′-UTR region. Polymorphisms in 5′-
UTR and 3′-UTR might have effects on the translation and
stability of the genes. We selected these polymorphisms as
candidates in this study.
METHODS
Patients: From February to November 2004, we measured the
refractive error in 3,000 volunteers. All of the participants
were  medical  students,  unrelated  and  Taiwan-born  Han
Chinese (Table 1). The included subjects had a visual acuity
with distance correction of 0.2 logMAR (logarithm of the
minimal angle of resolution; 20/32) or better. The included
subjects did not have any systemic diseases. They also did not
receive ocular surgery before. Refractive error was measured
in  diopters  (D)  and  determined  by  the  mean  spherical
equivalent  (SE)  of  the  two  eyes  of  each  individual  after
administering one drop of cycloplegic drug (1% mydricyl;
Alcon, Berlin, Germany). Individuals with −6.5 D or a more
negative refractive error (both eyes) were included in the study
group, and those with myopia between −0.5 D and +1.0 D
(both eyes) were included in the control group. Patients with
astigmatism with a refractive error more negative than -0.75
D were excluded from the study. Other volunteers did not meet
the criteria to be included in either the study or control groups,
and  they  were  excluded  from  our  study.  Our  study  was
reviewed by the ethics committee, and informed consent was
obtained from all patients and control subjects. The study was
performed  according  to  the  tenets  of  the  Declaration  of
Helsinki  for  research  involving  human  subjects.
Comprehensive  ophthalmic  examinations  and  blood
collection  were  performed.  As  with  all  data  collection
procedures,  auto-refraction  (Auto-refractor/auto-
keratometer; ARK 700A; Nikon, Tokyo, Japan) was taken on
both eyes by experienced optometrists who were trained and
certified  on  study  protocols.  Refractive  data,  sphere(s),
negative cylinder©, and axis measurements were analyzed by
calculating refractive error with SE.
Genotype  determinations:  The  single  nucleotide
polymorphisms (SNPs) were selected based on three criteria.
(1)  The  selected  SNP  had  a  frequency  in  the  CHB  (Han
Chinese in Beijing, China) or JPN(Japanese) population as
documented in the HapMap project, and the heterozygosity
should be more than 10%. (2) The selected SNP should be in
the region of the promoter, 5′-UTR, exons, and 3′-UTR of the
gene. We excluded any intron SNP because it is hard to predict
the outcome of the polymorphism. (3) In exons, only non-
synonymous SNPs were selected. Based on these criteria, only
a few SNPs could be selected. For FMOD, the selected SNP
was based on sequencing experiments. The exons of FMOD
were sequenced among 50 randomly selected individuals to
reveal the SNPs in FMOD. Only one SNP was detected. As
for selecting haplotype, HapMap genotypes were analysed
within Haploview and tag SNPs were selected using tagger.
Four tag SNPs were selected for each gene with r2≥0.80 to
capture  80%  of  genotype  information  in  the  region.  The
average tag SNP was with r2=0.901.
In this study, we used high resolution melting (HRM)
genotyping  and  restriction  fragment  length  polymorphism
(RFLP) genotyping to detect the SNPs. Genomic DNA was
extracted from whole blood samples after a standard protocol
of digestion by proteinase K and purification with phenol-
chloroform. RFLP was used to detect genotypes of TGF-b2
(rs991967), bFGF (rs308395), and FMOD (rs7543148). The
amplification  protocol  and  restriction  enzymes  used  to
determine  the  genotype  are  listed  in  Table  2.  Preventive
contamination  measures  were  taken  by  including  a
polymerase chain reaction (PCR) reaction mixture without
DNA (negative control) in each run of amplification. The
DNA fragments were separated by horizontal electrophoresis
on  3%  agarose  gels,  stained  with  ethidium  bromide,  and
photographed under ultraviolet lights. Data were analyzed by
ABI  prism  GeneMapper  Version  3.0  software  (Applied
Biosystems Co, Foster City, CA). The PCR product of TGF-
β2 (rs991967) was digested with HpyCH4III (New England
Biolabs, Mississauga, Ontario, Canada). The A allele size was
239 bp, and the C allele size was 100 bp+139 bp as shown in
Figure  1.  The  PCR  product  of  bFGF  (rs308395)
polymorphism  was  digested  with  BsrI  (New  England
TABLE 1. CHARACTERISTICS OF THE STUDY SUBJECTS.
Characteristics Control (n=94) Cases (n=195) All subjects (n=289)
Age, mean (SD), yr 18 (2.9) 18 (3.4) 18 (3.2)
Female, Number (%) 33 (35.1%) 70 (35.9%) 103 (35.6%)
SE, mean (SD), D 0.02 (0.32) −8.83 (2.5) −4.5 (4.8)
AXL, mean (SD), mm 23.56 (0.78) 26.8 (1.8) 24.8 (2.5)
CD, mean (SD), D 43.5 (0.9) 44.2 (1.9) 43.8 (1.5)
ACD, mean (SD), mm 3.56 (0.25) 3.88 (0.33) 3.62 (0.3)
LT, mean (SD), mm 3.8 (0.65) 4.0 (0.58) 3.9 (0.6)
SE: spherical equivalent, AXL: axial length, CD: cornea diopter, ACD: anterior chamber depth, LT: lens thickness.
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1656Biolabs). The C allele size was 241 bp, and the G allele size
was 163 bp+78 bp as shown in Figure 2. The PCR product of
the FMOD (rs7543148) genetic polymorphism was digested
with BsmI (New England Biolabs). The G allele size was
1,033 bp, and the A allele size was 751 bp+282 bp as shown
in Figure 3.
In this study, HRM genotyping was used to detect the
SNPs of TGF-β2 (rs7550232) and bFGF (rs41348645). Real-
time PCR amplification of the 16S rRNA gene was performed
in  a  LightCycler®  480  High  Resolution  Melting  Master
(Roche  Diagnostics  Co,  Mannheim,  Germany)  with  the
primer pairs listed in Table 2. Briefly, genomic DNA (50 ng)
was added to a 10 µl reaction mixture containing 0.5 µmol/l
and 2 mmol/l MgCl2 of each primer. Cycling conditions are
listed in Table 2. We also compared the haplotypes of these
polymorphisms  in  their  susceptibility  to  high  myopia.
Haplotypes were inferred from unphased genotype data using
the  Bayesian  statistical  method  available  in  the  software
program, Phase 2.1. All five SNPs were analyzed with the
Figure  1.  The  PCR  product  of  TGF-β2  (rs991967)  genetic
polymorphism The PCR product of TGFβ2-rs991967 was digested
with HpyCH4III. The “A” allele was 239 bp and the “C” allele was
100 bp + 139 bp.
Figure 2. The PCR product of bFGF (rs308395) polymorphism. The
PCR product of βFGF2-rs308395 polymorphism was digested with
BsrI. The “C” allele was 241 bp and the “G” allele was 163 bp + 78
bp.
Phase 2.1 software [14]. We defined haplotype 1 (Ht 1) to
haplotype 4 (Ht 4) as the alternative allelic composition of the
TGF-β2 and bFGF polymorphisms. They are defined in Table
3.
Statistical  analysis:  Genotypes  were  obtained  by  direct
counting with subsequent calculation of allele frequencies.
Data  were  analyzed  using  the  χ2  test,  and  p  values  were
calculated using the Minitab program (Minitab Inc., San Jose,
CA). A p value less than 0.05 was considered significant.
Adherence  to  the  Hardy–Weinberg  equilibrium  (HWE)
constant was tested using a χ2 test with one degree of freedom.
The odds ratios (OR) and the corresponding 95% confidence
intervals (CI) were calculated with reference to the allele and
genotype.  Correction  for  multiple  comparisons  was
performed by Bonferroni correction. For the SNPs that were
found  to  be  significant  after  multiple  testing  corrections,
stepwise logistic regression was used to determine if any of
these SNPs could account for the effects of the other positive
SNPs. STATA package (version 8.2; Stata Corp., College
Station,  TX)  was  used  to  perform  the  stepwise  logistic
regression.
RESULTS
The volunteers who enrolled in this study all met specific
criteria: age ranging from 16 to 25 years (mean age, 18±3.2
years), male-to-female ratio of 1.8–1.0, mean axial length
(AXL) of 24.8 mm, and mean spherical equivalent (SE) of 4.5
D. There were no significant differences between the control
and cases groups in age, gender, cornea diopter (CD), anterior
chamber depth (ACD), and LT (lens thickness; by Zeiss IOL
master [Zeiss Inc, Boston, MA]; Table 1). The study group
comprised of 195 patients with high myopia, and the control
group  consisted  of  94  control  subjects.  The  TGF-β2
(rs991967) genotypes were A/A, A/C, and C/C (Figure 1). The
genotype and allele distribution of the TGF-β2 (rs991967)
polymorphism  did  not  differ  significantly  between  high
myopia patients and normal controls (p=0.437 and p=0.169, ,
respectively; Table 4). The bFGF (rs308395) genotypes were
G/G,  C/G,  and  C/C  (Figure  2).  The  genotype  and  allele
Figure 3. The PCR product of FMOD exon 2 codon 79 genetic
polymorphism. The PCR product of FMOD exon 2 codon 79 genetic
polymorphism was digested with BsmI. The “G” allele was 1,033 bp
and the “A” allele was 751 bp + 282 bp.
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1658distributions of the bFGF (rs308395) polymorphism did not
differ significantly between high myopia patients and normal
controls (p=0.215 and p=1.0, respectively; Table 4). In the
FMOD (rs7543418) genetic polymorphism, the genotype and
allele distributions of the FMOD (rs7543148) polymorphism
also did not differ significantly between high myopia patients
and  normal  controls  (p=0.362  and  p=0.129,  respectively;
Table 4).
HRM was used to detect SNPs of TGF-β2 (rs7550232)
and bFGF (rs41348645). The TGF-β2 (rs7550232) genetic
polymorphism was studied by HRM on a LightCycler 480.
The results are shown in Figure 4. The genotype distribution
of  the  TGF-β2  (rs7550232)  polymorphism  differed
significantly  between  high  myopia  patients  and  normal
controls (p=0.03; Table 4). The allelic frequency also differed
significantly between the two groups (p=0.0178; Table 4).
The genetic polymorphism, bFGF (rs41348645), was also
studied by HRM. The results are shown in Figure 5. There was
no significant difference in genotype and allele distributions
of  the  bFGF  (rs41348645)  polymorphism  between  high
myopia  patients  and  normal  controls  (p=0.1294  and
p=0.0958, respectively; Table 4).
The  haplotypes’  distribution  of  the  TGF-β2
polymorphisms (Ht 1 [A/C], Ht 2 [A/A], and Ht 3 [C/C]) and
Figure  4.  The  TGF-β2  (rs7550232)  genetic  polymorphism.  The
TGFβ2-rs7550232 genetic polymorphism was studied by HRM and
analyzed  by  LightCycler  480.  The  TGFβ2-rs7550232  genetic
polymorphism had three genotypes and they were “CC”, “AC” and
“AA”.
bFGF polymorphisms (Ht1 [C/A], Ht2 [C/G], and Ht3 [G/A])
were  compared  between  the  high  myopia  group  and  the
control group (Table 3). The cases’ numbers of Ht4 in TGF-β2
polymorphisms and Ht4 of bFGF polymorphisms were too
small and under powered to analyze (Table 3). Therefore, they
were excluded in this analysis. In the analysis of haplotypes,
we  found  that  the  distribution  of  Ht  2  (A/A)  in  TGF-β2
polymorphisms differed significantly between the two groups
(p=0.014;  Table  3).  However,  there  was  no  significant
difference in the distribution of Ht 1 and Ht 3 of TGF-β2
between the two groups (p=0.736 and p=0.101; Table 3). As
for  the  haplotypes’  distribution  in  FGF-2,  there  was  no
significant difference in the distribution of all haplotypes of
FGF2 Ht 1 (C/A), Ht 2 (C/G), and Ht 3 (G/A) between the
high myopia group and the control group (p=0.458, p=0.360,
and p=0.058, respectively; Table 3).
A stepwise logistic regression procedure was used to
detect  which  of  the  significant  SNPs  contributed  to  the
development of high myopia (Table 5). By the backward
procedure, eliminated S5 (FMOD [AGT→AAT]), S4 (bFGF
[rs41348645],  S3  (bFGF  [rs3083959]),  and  S2  (TGF-β2
[rs991967]) from the model did not have any significant effect
(p=0.3819, 0.2014, 0.128, and 0.158, respectively; Table 5).
Figure  5.  The  bFGF  (rs41348645)  genetic  polymorphism.  The
βFGF2-rs41348645 genetic polymorphism was studied by HRM and
analyzed  by  LightCycler®  480.  The  βFGF2-rs41348645  genetic
polymorphism had three genotypes and they were “GG”, “AG” and
“AA”.
TABLE 3. GENE HAPLOTYPES OF TGF-Β2 RS7550232/RS991967AND ΒFGF RS308395/RS41348645.
SNPs Haplotype                    Controls (%)                Cases (%)                     OR (95% CI) p value
TGF-β2 rs7550232/rs991967 Ht1 A/C 126 (67.0%) 258 (66.1%) 0.94 (0.65–1.35) 0.736
  Ht2 A/A 30 (16.0%) 96 (24.60%) 1.75 (1.12–2.75) 0.014
  Ht3 C/C 26 (13.8%) 36 (9.20%) 0.64 (0.37–1.09) 0.101
  Ht4 C/A 6 (3.1 %) 0 (0.00%) - N#
bFGF rs308395/rs41348645 Ht1 C/A 116 (61.7%) 226 (57.9%) 0.88 (0.62–1.24) 0.458
  Ht2 C/G 48 (25.5%) 114 (29.2%) 1.2 (0.81–1.77) 0.360
  Ht3 G/A 24 (12.8%) 32 (8.2%) 0.59 (0.34–1.02) 0.058
  Ht4 G/G 0 (0%) 18 (4.6%) - N#
#; The case number was too small and under power for analyzing.
Molecular Vision 2009; 15:1655-1663 <http://www.molvis.org/molvis/v15/a177> © 2009 Molecular Vision
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1660In  conclusion,  the  stepwise  regression
procedure  demonstrated  that  S1  (TGF-β2  [rs7550232])
significantly  contributed  the  development  of  high  myopia
(p=0.004) (Table 5).
DISCUSSION
Some genes have been found to be closely related to high
myopia such as matrix metalloproteinases [15], paired box 6
[16],  myocilin  [17],  TGF-β1  [18],  Paired  box  gene  6
(PAX-6) [19], and Collagen, type I, alpha 1 (COL1A1) [20].
These genes all indicate an evident predisposition for the
development of high myopia. However, none of these genes
have been found to be solely responsible for the development
of myopia in different ethnic groups or to cover all myopia
patients [15-21]. The other difficulty in myopic study is the
uncertainty  of  what  are  the  surrounding  environmental
influences  that  promote  the  progression  of  myopia.
Individuals with a higher education have a higher prevalence
of myopia than people in the general population, which is why
students in a medical school were chosen as candidates in this
study. The medical school’s students in this study decreased
the bias of environmental influence.
In this study, we found that the distribution of the TGF-β2
(rs7550232) A/A genotype and A allele differed significantly
between the myopia and control groups. The A/A genotype
and A allele of TGF-β2 (rs7550232) had a protective effect
against myopia (Table 4). In the analysis of haplotypes, we
found that Ht 2 (A/A) of TGF-β2 was significantly different
in the incidence of high myopia. The frequency of the Ht 2
(A/A) of TGF-β2 was higher in the control group then in the
myopia  group  (p=0.014),  indicating  that  Ht  2  of  TGF-β2
polymorphisms had a protective effect against myopia. In
TGF-β2,  combining  the  analyses  of  allelic  and  haplotype
study,  we  could  indicate  that  the  A  allele  of  TGF-β2
(rs7550232) had a protective effect against high myopia, and
its effect would increase when the subjects had the A allele in
TGF-β2 (rs991967; Ht2 [A/A] of TGF-β2; Table 3). As for
bFGF, the frequencies of the haplotypes were all without
significant  differences  between  the  two  groups  (Table  3).
According to our study, the genetic polymorphisms in bFGF
did not play any important role in the suffering of high myopia.
Besides,  the  results  of  stepwise  regression
procedure  demonstrated  that  S1  (TGF-β2  [rs7550232])
contributed  significantly  to  the  development  of  myopia
(p=0.04) (Table 5). There were no significant effects when S5
(FMOD [rs7543148]), S4 (bFGF [rs41348645]), S3 (bFGF
[rs3083959]), and S2 (TGF-β2 [rs991967]) were eliminated
from the model (Table 5). This also reinforced the importance
of TGF-β2 (rs7550232) in the development of high myopia.
In the check of the Hardy–Weinberg equilibrium (HWE), all
SNPs in this study obeyed HWE except bFGF (rs41348645;
Table 4). To validate our findings, we repeated the genotyping
analysis several times and consistent results were obtained.
The errors in genotyping were kept to a minimum. We tried
to trace the ancestry background of the controls and patients
to  check  the  probability  of  population  stratification.
According to the paper published by Pan et al. [22], they
mentioned  that  on  the  SNP  profiles  in  the  major
histocompatibility  complex  (MHC)  region  (6p21.3),  the
composition of our population is as follows: 85% are Minnan
descendants, 5% are Hakka descendants, and the remaining
10% are mixed population of Minnan, Hakka, and Canton
descendants. There was no significant difference in the MHC
region among these groups, this indicated that the population
in this study was homogeneous and population stratification
should not affect this study. Moreover, the deviations from
HWE might be a sign of mutation. This disequilibrium seems
to also support the association of the polymorphisms in TGF-
β2 with high myopia.
The expression of TGF-β1 and TGF-β2 were different in
myopia. A study by Hayashi et al. [23] revealed that there was
no significant relationship between high myopia and TGF-β1
among the Japanese [23]. Furthermore, Kusakari et al. [24]
reported that TGF-β1 expression was reduced in the sclera,
choroid, and retina during myopia development in an isoform-
and time-specific manner. However, it has been shown that
the TGF-β2 content increased in the retina, choroid, and sclera
during myopia development [25]. In this study, we found that
expression of TGF-β2 was different from the result of TGF-β1
among the Japanese. The different expressions of TGF-β2 and
TGF-β1  in  myopia  could  be  understood  by  the  different
behavior of the two isoforms in sclera during the progression
of myopia. Moreover, our other study has found that the CC
genotype  in  the  TGF-β1  codon  10  polymorphism
(rs1982073) contributes to the genetic predisposition of high
myopia [18]. The SNP we detected (TGF-β1 [rs1982073])
TABLE 5. SNPS ANALYZED BY STEPWISE LOGISTIC REGRESSION PROCEDURE
Null model Alternative model p value
S1+S2+S3+S4+S5 S1+S2+S3+S4 0.3819
S1+S2+S3+S4+S5 S1+ S2+S3+S5 0.2014
S1+S2+S3+S4+S5 S1+S2+S4+S5 0.128
S1+S2+S3+S4+S5 S1+S3+S4+S5 0.158
S1+S2+S3+S4+S5 S2+S3+S4+S5 0.004
S1: TGF-β2 -rs7550232, S2:  TGF-β2 -rs991967, S3:  βFGF -rs308395, S4:  βFGF -rs41348645, S5:  FMOD -rs7543148 .
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1661was not the purpose in the study of Hayashi et al. [23], which
is about the relation of TGF-β1 and myopia in the Japanese.
To refine the role of TGF-β1 in myopia, it is still necessary to
study the expression of TGF-β1 in other populations. Studies
on the TGF-β-induced factor gene (TGIF) [26] had revealed
that TGIF 657 T→G was a useful marker for high myopia.
The target genes of these studies were related to TGF-β1 and
not TGF-β, which was surveyed in this study. These data may
be collected together for mapping high myopia in the future.
TGF-β  is  one  of  the  growth  factors  released  from
photoreceptor  and  retina  pigment  epithelium  layer  in  the
retina [27], TGF-β demonstrated a different broad range of
function  [28].  A  previous  study  had  proposed  that  the
concentration of TGF-β mRNA and active form of the TGF-β
protein  will  decrease  in  the  form-deprived  myopia  eyes
compared with the control group [29]. Consequently, TGF-β
may  mediate  the  control  of  ocular  axial  elongation  then
influence the progression of high myopia [29]. A recent study
about TGF-β revealed that reduced scleral TGF-β is a major
contributor  to  the  extracellular  matrix  remodeling  in  the
myopic eye. In the progression of myopia, remodeling of
scleral and producing a larger population of contractile cells
are the important process [28]. These findings all revealed that
important role of TGF-β in myopia. The function assay of
TGFb2-rs7550232  and  the  genetic  regulation  the  SNP  is
worthy of further investigation.
Myopia is considered to be a complex and multigenic
disease  involving  several  overlapping  signaling  pathways,
each one mediated by a group of distinct genetic profiles.
Therefore,  it  is  important  to  study  the  polymorphisms
involved in the development of myopia to further clarify the
relationship  between  genes  and  myopia.  In  this  study  we
prevented the effects of environment by selected the study and
control groups from medical school students. Nevertheless,
the “environment” effects cannot be completely prevented.
Moreover, the incidence of myopia in our country increased
in the past 20 years [30]; these all indicated that the effective
of environment would not be over-emphasized. Although the
results of this study could give us the genetic information of
myopia, the prevention of high myopia still needs the efforts
of eye doctors and the association of public health.
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